Acrivon Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

7.01,8.01,9.01

7.01,8.01,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

Free Writing Prospectus

Notice of Effectiveness

Amended Initial Registration Statement

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Amended Initial Registration Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Required Information in Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Levin Michaela

Levin Michaela

Blume-Jensen Peter; Masson Kristina

Blume-Jensen Peter

Devroe Eric

Peterson Katharine

Miller Mary

Blume-Jensen Peter; Masson Kristina

Gamelin Erick

Sands Capital Life Sciences Pulse Fund II, L.P.

Levy Adam D.

Miller Mary

Shacham Sharon

TOMSICEK MICHAEL JOHN

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.; Kolchinsky Peter

DiRocco Derek

Magovcevic-Liebisch Ivana

Palani Santhosh

BAUM CHARLES M

Blume-Jensen Peter; Masson Kristina

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

No description available

Letter from the SEC

Draft registration statement (confidential submission)